<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03413631</url>
  </required_header>
  <id_info>
    <org_study_id>13924</org_study_id>
    <nct_id>NCT03413631</nct_id>
  </id_info>
  <brief_title>A Prenatal Mentalization-focused 4D Ultrasound and a Pregnancy Diary Intervention for Substance-abusing Women</brief_title>
  <official_title>A Prenatal Mentalization-focused 4D Ultrasound and a Pregnancy Diary Intervention for Substance-abusing Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Foundation for Paediatric Research, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academy of Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital District of Southwestern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: This randomized and controlled trial was aimed at exploring the effect of a new
      mentalization-focused 4D interactive ultrasound and a week-by-week pregnancy diary
      intervention with substance-abusing pregnant women.

      Method: Pregnant women referred to the hospital maternity outpatient clinic from primary
      health care due to substance abuse were recruited to participate in a randomized and
      controlled study. At admission, a psychiatric nurse offered all eligible women an opportunity
      for participation. A written informed consent was obtained from all participants included in
      the study. The participants were randomized into the intervention and control groups using a
      computer-generated block-randomization with block size of four. A separate randomization
      assignment was used for women in medication-assisted treatment for opioid dependence.

      The intervention group subjects were offered three mentalization-focused interactive 4D
      ultrasounds at 24, 30 and 34 gestational weeks and a mentalization-focused week-by-week
      pregnancy diary combined with three antenatal sessions and an option for one diary session
      after delivery. The control group received active treatment as usual in an obstetric tertiary
      setting.

      The pregnant woman and the child were followed-up until the child was one year old. The
      primary outcome was prenatal maternal depressive symptoms post-intervention, and secondary
      outcomes were anxiety symptoms, prenatal parental mentalization, maternal-fetal attachment
      and substance abuse. Other outcomes were utilisation of prenatal care, perinatal outcome,
      neonatal withdrawal symptoms and neonatal neurobehavior, postnatal maternal depressive and
      anxiety symptoms, parental mentalization, experienced stress from parenting and experienced
      social support, and emotional connection and commitment with the baby.

      The study was conducted at the hospital maternity outpatient clinic for substance-abusing
      pregnant women at Turku University Hospital (Finland) between October 2011 and December 2015.
      The registration of the trial is made retrospectively, but the research plan and outcomes are
      reported in this registration as they were originally documented in the research plan
      approved by The Joint Ethics Committee of the University of Turku and the Hospital District
      of Southwest Finland on 14th of June 2011.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective:

      The aim of this controlled trial was to explore the effect of a new mentalization-focused 4D
      interactive ultrasound and a week-by-week pregnancy diary intervention with substance-abusing
      pregnant women.

      Method:

      This trial was conducted at the maternity outpatient clinic for substance-abusing pregnant
      women at Turku University Hospital, Finland, between October 2011 and December 2015. At Turku
      University Hospital there is a specialized antenatal outpatient clinic for pregnant women
      with substance abuse problems. Pregnant women referred to this facility from primary health
      care due to substance abuse were invited to participate the trial.

      At admission, a psychiatric nurse offered all eligible women an opportunity to participate in
      the randomized trial. A written informed consent was obtained from all individual
      participants included in the study. The participants were randomized into the intervention
      and control groups using a computer-generated block-randomization with block size of four,
      and a separate randomization assignment was used for women in medication-assisted treatment
      for opioid addiction. In post-intervention phase at 35 gestational weeks, all participants
      were compensated with a 20 euros gift card targeted to the infant's needs. The research plan
      was approved by The Joint Ethics Committee of the University of Turku and the Hospital
      District of Southwest Finland on the 14th of June 2011.

      Description of the intervention and the control condition:

      The intervention group subjects were offered three mentalization-focused interactive 4D
      ultrasounds at 24, 30 and 34 gestational weeks and a mentalization-focused week-by-week
      pregnancy diary combined with three prenatal sessions and option for one diary session after
      delivery. Detailed intervention method description including a theoretical background of the
      intervention is already published and available (Pajulo et al. 2016).

        1. Mentalization-focused interactive use of 4D ultrasound imaging:

           Three interactive 4D ultrasound sessions were offered for the intervention group
           participants at 24, 30 and 34 gestational weeks at the maternity outpatient clinic. The
           pregnant women participated in the sessions alone. The ultrasound sessions took around
           20-30 minutes, and were performed by an experienced obstetrician and an infant mental
           health professional working in cooperation. The sessions were based on the intervention
           method called &quot;ultrasound consultation&quot; (Boukydis &amp; Stockman, 2012; Boukydis, 2006)
           where the idea is to observe the fetus together with the parent(s); the fetal features,
           position, sleep-awake rhythm, personal characteristics, activities in the uterus and
           responses to mother's initiatives for interaction.The aim is to evoke the mother`s
           active interest in this particular child and hence to enhance parental mentalization and
           maternal-fetal attachment.

        2. The mentalization-focused week-by-week pregnancy diary:

      To keep the fetus more actively in the mother's mind across pregnancy, a new
      mentalization-focused pregnancy diary was designed for the intervention group. Three prenatal
      meetings (45 minutes) with the infant mental health professional were offered for reflecting
      the mother's experiences on using the diary. The diary contains short sections for each
      pregnancy week including information about pregnancy, fetal development and health promoting
      practices. The key elements in the diary are the mentalization-focused questions and tasks
      encouraging the pregnant woman to reflect on her fetus and pregnancy and becoming a parent.

      The control condition:

      The intervention and control group received active treatment as usual in an obstetric
      tertiary setting, and treatment as usual formed the control condition for the intervention.
      The treatment was offered by a multidisciplinary team consisting of an obstetrician, a
      midwife, a social worker and a psychiatric nurse . The patients were referred to addiction
      and psychiatric treatment when needed. The Child Protection Services were involved in
      prenatal phase in accordance with the Finnish legislation.

      Data collection:

      The primary outcome was prenatal maternal depressive symptoms post-intervention, and
      secondary outcomes were anxiety symptoms, prenatal parental mentalization, maternal-fetal
      attachment and substance abuse. Other outcomes were utilisation of prenatal care, perinatal
      outcome, neonatal withdrawal symptoms and neonatal neurobehavior, postnatal maternal
      depressive and anxiety symptoms, parental mentalization, experienced stress from parenting
      and experienced social support, and emotional connection and commitment with the baby.

      The pregnant woman and her child were followed-up until the child was one year old. The data
      was collected from multiple sources: standardized measures, questionnaires constructed for
      the study and information available from hospital medical records. As a part of routine
      clinical practice, the pregnant women were interviewed by the psychiatric nurse and the
      social worker. The interviews based on the European Addiction Severity Index-questionnaire
      (EuropASI) (Kokkevi &amp; Hartgers, 1995), where the items regard maternal physical and mental
      health, substance abuse, employment and income, legal status and close relationships.
      Sociodemographic data was obtained by a ten-item questionnaire at baseline. Information
      regarding maternal psychiatric diagnosis and/or history was based on documented self-report
      or medical records. Information regarding maternal substance abuse was obtained through the
      medical records, and was based on maternal self-report or clinical documentation
      (intoxications, urine screening results, marks indicating intravenous substance abuse).
      Meconium sample was collected after birth for detection of illicit drugs. Data regarding
      utilisation of obstetric care and perinatal outcome was obtained from hospital medical
      records.

      The standardized measures used to assess maternal depressive and anxiety symptoms,
      maternal-fetal attachment and parental mentalization were administered during pregnancy at
      two time points, i.e. before and after intervention (&lt; 24th and &gt; 34th gestational weeks,
      respectively). Routine postnatal follow-up visits at the socio pediatric unit were conducted
      when the infant was at 3 months and 1 year age. Standardized measures were administered
      during those follow-up visits to assess maternal postnatal depressive and anxiety symptoms,
      parental mentalization, experienced stress from parenting and experienced social support, and
      emotional connection and commitment with the baby. Medical records concerning health and
      psychosocial situation of the mother and infant were available, based on informed consent,
      until the child was one year old. The assessment time points and measures were the same for
      both groups.

      The registration of the trial is made retrospectively, but the research plan and outcomes are
      reported in this registration as they were originally documented in the research plan
      approved by The Joint Ethics Committee of the University of Turku and the Hospital District
      of Southwest Finland on 14th of June 2011.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 18, 2011</start_date>
  <completion_date type="Actual">December 31, 2015</completion_date>
  <primary_completion_date type="Actual">December 31, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The participants were randomized into the intervention and control groups using a computer-generated block-randomization with block size of four. A separate randomisation assignment was used for women medication-assisted treatment for opioid addiction.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prenatal depressive symptoms post-intervention at 35 gestational weeks</measure>
    <time_frame>Post-intervention at 35 gestational weeks</time_frame>
    <description>Assessment of prenatal depressive symptoms with Edinburgh Pre/Postnatal Depression Scale (EPDS); theoretical range of total scale (minimum and maximum scores) 0-30 points and lower total score indicating lower level of depressive symptoms and better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prenatal parental mentalization post-intervention at 35 gestational weeks</measure>
    <time_frame>Post-intervention at 35 gestational weeks</time_frame>
    <description>Assessment of prenatal parental mentalization with Prenatal Parental Reflective Functioning Questionnaire (P-PRFQ): theoretical range of the sum index is 1-7 points (minimum and maximum scores), and higher total score is indicating higher level of parental mentalization and better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal-fetal attachment post-intervention at 35 gestational weeks</measure>
    <time_frame>Post-intervention at 35 gestational weeks</time_frame>
    <description>Assessment of maternal-fetal attachment with Maternal-fetal Attachment Scale (MFAS): theoretical range of total scale is 24-120 points (minimum and maximum scores), and higher total score is indicating stronger maternal-fetal attachment and better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prenatal maternal substance abuse (health behaviour)</measure>
    <time_frame>From date of randomization until the date of delivery, assessed up to 42 gestational weeks</time_frame>
    <description>Prenatal clinical assessments of prenatal substance abuse documented in the hospital medical records (intoxications, urine screening results, marks indicating intravenous substance abuse): The more findings, the worse the outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prenatal anxiety symptoms post-intervention at 35 gestational weeks</measure>
    <time_frame>Post-intervention at 35 gestational weeks</time_frame>
    <description>Assessment of prenatal anxiety symptoms with The State Section of The State-Trait Anxiety Inventory (STAI): theoretical range of total scale is 20-80points (minimum and maximum scores), and lower total score is indicating lower level of prenatal anxiety and better outcome.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Prenatal care</measure>
    <time_frame>From date of randomization until the date of delivery, assessed up to 42 gestational weeks</time_frame>
    <description>Utilization of obstetric and emergency department hospital care at the Turku University Hospital (medical record data concerning outpatient visits, hospital admissions)</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal child outcome: Birth weight</measure>
    <time_frame>After birth up to 1 day</time_frame>
    <description>Birth weight of the neonate in grams(g)</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal child outcome: Gestational age</measure>
    <time_frame>After birth up to 1 day</time_frame>
    <description>Gestational age of the neonate in gestational weeks</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal child outcome: Apgar Score at 5 minutes</measure>
    <time_frame>5 minutes after birth</time_frame>
    <description>Apgar score of the neonate at 5 minutes age. Apgar score total range is 0-10 points (minimum and maximum scores), and higher total score indicates better neonatal outcome</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal child outcome: Head circumference</measure>
    <time_frame>After birth up to 1 day</time_frame>
    <description>Head circumference in centimeters(cm)</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal child outcome: Length of hospital stay after birth</measure>
    <time_frame>After birth up to 1 month</time_frame>
    <description>Duration of the neonate's hospital care in days</description>
  </other_outcome>
  <other_outcome>
    <measure>Fetal drug exposure</measure>
    <time_frame>After birth up to 7 days</time_frame>
    <description>Meconium sample for testing exposure to illicit drugs</description>
  </other_outcome>
  <other_outcome>
    <measure>Postnatal depressive symptoms</measure>
    <time_frame>3 months and 1 year after delivery</time_frame>
    <description>Assessment of postnatal depressive symptoms with Edinburgh Postnatal Depression Scale (EPDS); theoretical range of the total scale is 0-30 points (minimum and maximum scores), and lower total score is indicating lower level of depressive symptoms and better outcome.</description>
  </other_outcome>
  <other_outcome>
    <measure>Postnatal anxiety symptoms</measure>
    <time_frame>3 months and 1 year after delivery</time_frame>
    <description>Assessment of postnatal anxiety symptoms with The State Section of The State-Trait Anxiety Inventory (STAI): theoretical range of the total scale is 20-80 points (minimum and maximum scores), and lower total score is indicating lower level of postnatal anxiety and better outcome.</description>
  </other_outcome>
  <other_outcome>
    <measure>Postnatal parental mentalization</measure>
    <time_frame>3 months and 1 year after delivery</time_frame>
    <description>Assessment of postnatal parental mentalization with Parental Reflective Functioning Questionnaire (PRFQ): theoretical range sum index 1-7 points, higher score indicating better outcome (higher mentalization)</description>
  </other_outcome>
  <other_outcome>
    <measure>Experienced parenting stress and social support</measure>
    <time_frame>3 months and 1 year after delivery</time_frame>
    <description>Assessment of experienced stress in parenting and social support with Parenting Stress Index and Social Support (SPSQ): 15 items in section measuring experienced stress, sum index theoretical range 1-5 points (minimum and maximum scores), higher score indicating worse outcome (higher stress).</description>
  </other_outcome>
  <other_outcome>
    <measure>Emotional connection and commitment with the baby</measure>
    <time_frame>3 months and 1 year after delivery</time_frame>
    <description>Assessment of mother's emotional connection and commitment with the baby with Postpartum Bonding Questionnaire (PBQ): theoretical range sum index 1-5 (minimum and maximum scores), higher score indicating worse outcome (weaker bonding)</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal neurobehavior status</measure>
    <time_frame>After birth up to 7 days</time_frame>
    <description>Assessment of neonatal neurobehavior with Dubowitz Scale: 34 items scored with theoretical range 0-1 and total score theoretical range 0-34 points (minimum and maximum scores), higher score indicating better outcome.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Substance-Related Disorders</condition>
  <condition>Pregnancy, High Risk</condition>
  <condition>Prenatal Care</condition>
  <condition>Maternal-Fetal Relations</condition>
  <condition>Parenting</condition>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <condition>Perinatal Outcome</condition>
  <condition>Fetal Exposure During Pregnancy</condition>
  <arm_group>
    <arm_group_label>Prenatal mentalization intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention group participants were offered three mentalization-focused 4D interactive ultrasounds at 24, 30 and 34 gestational weeks and a mentalization-focused week-by-week pregnancy diary combined with three prenatal sessions and option for one session after delivery in addition to obstetric care as usual (see Prenatal obstetric treatment as usual).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prenatal obstetric treatment as usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group received obstetric care as usual in a tertiary setting. The comprehensive treatment as usual was conducted at the hospital antenatal outpatient clinic, including regular obstetric ultrasounds. The multidisciplinary treatment team, consisting of an obstetrician, a midwife, a social worker and a psychiatric nurse, assess and support health and psychosocial situation of the pregnant woman. The pregnant woman was referred to addiction and psychiatric treatment when needed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prenatal mentalization intervention</intervention_name>
    <arm_group_label>Prenatal mentalization intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prenatal obstetric treatment as usual</intervention_name>
    <arm_group_label>Prenatal mentalization intervention</arm_group_label>
    <arm_group_label>Prenatal obstetric treatment as usual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Pregnant women referred to the hospital maternity outpatient clinic from primary health
        care due to substance abuse were recruited to participate in a randomized and controlled
        study. The subjects were referred from primary health care due to:

          1. documented or self-reported illicit drug use, misuse of prescription medication or
             alcohol within three years prior to or during this pregnancy,

          2. and/or sum score â‰¥ 3 points on TWEAK alcohol screening (Russell, 1994).

             The inclusion criteria included also:

          3. pregnancy duration &lt; 22 gestational weeks (gwks) at referral

          4. singleton pregnancy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only pregnant women (pregnancy duration &lt; 22 gestational weeks (gwks) at referral, and singleton pregnancy) were recruited</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eeva Ekholm, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology, Turku University Hospital, Kiinamyllynkatu 4-8, PL 52, 20521 Turku, Finland Department of Obstetrics and Gynecology, University of Turku, 20014 Turku, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marjukka Pajulo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Child Psychiatry, Turku University Hospital, Kiinamyllynkatu 4-8, PL 52, 20521 Turku, Finland Department of Child Psychiatry and Finn Brain, University of Turku, 20014 Turku, Finland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology and Department of Child Psychiatry, Turku University Hospital; Department of Obstetrics and Gynecology and Department of Child Psychiatry, University of Turku, Turku, Finland</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Boukydis CF, Treadwell MC, Delaney-Black V, Boyes K, King M, Robinson T, Sokol R. Women's responses to ultrasound examinations during routine screens in an obstetric clinic. J Ultrasound Med. 2006 Jun;25(6):721-8.</citation>
    <PMID>16731888</PMID>
  </reference>
  <reference>
    <citation>Boukydis Z. Ultrasound consultation to reduce risk and increase resilience in pregnancy. Ann N Y Acad Sci. 2006 Dec;1094:268-71.</citation>
    <PMID>17347359</PMID>
  </reference>
  <reference>
    <citation>Kokkevi, A., &amp; Hartgers, C. (1995). EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res, 1, 208-210.</citation>
  </reference>
  <reference>
    <citation>Pajulo H, Pajulo M, Jussila H, Ekholm E. SUBSTANCE-ABUSING PREGNANT WOMEN: PRENATAL INTERVENTION USING ULTRASOUND CONSULTATION AND MENTALIZATION TO ENHANCE THE MOTHER-CHILD RELATIONSHIP AND REDUCE SUBSTANCE USE. Infant Ment Health J. 2016 Jul;37(4):317-34. doi: 10.1002/imhj.21574. Epub 2016 Jun 24.</citation>
    <PMID>27341555</PMID>
  </reference>
  <reference>
    <citation>Russell, M. (1994). New risk assessment tools for risk drinking during pregnancy. T-ACE, TWEAK, and others. Alcohol Health &amp; Research World, 1, 55-61.</citation>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2018</study_first_submitted>
  <study_first_submitted_qc>January 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2018</study_first_posted>
  <last_update_submitted>January 22, 2018</last_update_submitted>
  <last_update_submitted_qc>January 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Eeva Ekholm</investigator_full_name>
    <investigator_title>Consultant, MD, PhD, Docent</investigator_title>
  </responsible_party>
  <keyword>prenatal substance abuse</keyword>
  <keyword>mentalization</keyword>
  <keyword>prenatal depression</keyword>
  <keyword>prenatal anxiety</keyword>
  <keyword>maternal-fetal attachment</keyword>
  <keyword>prenatal intervention</keyword>
  <keyword>ultrasound</keyword>
  <keyword>perinatal outcome</keyword>
  <keyword>fetal exposure</keyword>
  <keyword>parenting</keyword>
  <keyword>parenthood</keyword>
  <keyword>prenatal treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

